Article
Limited use of interleukin 28B in the setting of response-guided treatment with detailed on-treatment virological monitoring.
Hepatology (Baltimore, Md.) - 2 Sept 2011
Mangia Alessandra, Thompson Alexander J, Santoro Rosanna, Piazzolla Valeria, Copetti Massimiliano, Minerva Nicola, Petruzzellis Daniela, Mottola Leonardo, Bacca Donato, McHutchison John G
Abstract excerpt
UNLABELLED: A single-nucleotide polymorphism upstream of the interleukin-28B (IL28B) gene is associated with pegylated interferon-alfa-induced viral clearance in hepatitis C virus (HCV) genotype 1 patients. Using a well-characterized cohort of patients randomized to standard versus response-guided therapy, we studied whether the favorable CC type allows shortening of treatment duration. Association with viral...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
